Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Myasthenia Gravis Treatment Market, by End-use
1.4.2 Europe Myasthenia Gravis Treatment Market, by Type
1.4.3 Europe Myasthenia Gravis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Europe Myasthenia Gravis Treatment Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Clinics Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Myasthenia Gravis Treatment Market by Type
5.1 Europe Monoclonal Antibodies Market by Country
5.2 Europe Thymectomy Market by Country
5.3 Europe Cholinesterase Inhibitors Market by Country
5.4 Europe Chronic Immunomodulators Market by Country
5.5 Europe Rapid Immunotherapies Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Myasthenia Gravis Treatment Market by Country
6.1 Germany Myasthenia Gravis Treatment Market
6.1.1 Germany Myasthenia Gravis Treatment Market by End-use
6.1.2 Germany Myasthenia Gravis Treatment Market by Type
6.2 UK Myasthenia Gravis Treatment Market
6.2.1 UK Myasthenia Gravis Treatment Market by End-use
6.2.2 UK Myasthenia Gravis Treatment Market by Type
6.3 France Myasthenia Gravis Treatment Market
6.3.1 France Myasthenia Gravis Treatment Market by End-use
6.3.2 France Myasthenia Gravis Treatment Market by Type
6.4 Russia Myasthenia Gravis Treatment Market
6.4.1 Russia Myasthenia Gravis Treatment Market by End-use
6.4.2 Russia Myasthenia Gravis Treatment Market by Type
6.5 Spain Myasthenia Gravis Treatment Market
6.5.1 Spain Myasthenia Gravis Treatment Market by End-use
6.5.2 Spain Myasthenia Gravis Treatment Market by Type
6.6 Italy Myasthenia Gravis Treatment Market
6.6.1 Italy Myasthenia Gravis Treatment Market by End-use
6.6.2 Italy Myasthenia Gravis Treatment Market by Type
6.7 Rest of Europe Myasthenia Gravis Treatment Market
6.7.1 Rest of Europe Myasthenia Gravis Treatment Market by End-use
6.7.2 Rest of Europe Myasthenia Gravis Treatment Market by Type
Chapter 7. Company Profiles
7.1 AstraZeneca PLC (Alexion Pharmaceuticals, Inc.)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approval and Trails:
7.1.6 SWOT Analysis
7.2 Octapharma AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Research & Development Expenses
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approval and Trails:
7.4.6 SWOT Analysis
7.5 Allergan PLC (AbbVie, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.1 Research & Development Expense
7.5.2 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 GlaxoSmithKline PLC (GSK)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Bausch Health Companies Inc
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Kedrion S.p.A
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
7.9.4 SWOT Analysis
7.10. Zydus Lifesciences Ltd.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis



List of Figures

FIG 1 Methodology for the research
FIG 2 Europe Myasthenia Gravis Treatment Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Myasthenia Gravis Treatment Market
FIG 4 Porter’s Five Forces Analysis – Myasthenia Gravis Treatment Market
FIG 5 Europe Myasthenia Gravis Treatment Market share by End-use, 2022
FIG 6 Europe Myasthenia Gravis Treatment Market share by End-use, 2030
FIG 7 Europe Myasthenia Gravis Treatment Market by End-use, 2019 - 2030, USD Million
FIG 8 Europe Myasthenia Gravis Treatment Market share by Type, 2022
FIG 9 Europe Myasthenia Gravis Treatment Market share by Type, 2030
FIG 10 Europe Myasthenia Gravis Treatment Market by Type, 2019 - 2030, USD Million
FIG 11 Europe Myasthenia Gravis Treatment Market share by Country, 2022
FIG 12 Europe Myasthenia Gravis Treatment Market share by Country, 2030
FIG 13 Europe Myasthenia Gravis Treatment Market by Country, 2019 - 2030, USD Million
FIG 14 SWOT Analysis: AstraZeneca PLC
FIG 15 SWOT Analysis: Novartis AG
FIG 16 SWOT Analysis: Pfizer, Inc.
FIG 17 SWOT Analysis: Allergan PLC
FIG 18 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: GlaxoSmithKline PLC
FIG 20 SWOT Analysis: Bausch Health Companies Inc
FIG 21 SWOT Analysis: Kedrion S.p.A
FIG 22 SWOT Analysis: Zydus Lifesciences Ltd.

List of Tables

TABLE 1 Europe Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 2 Europe Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 3 Europe Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 4 Europe Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 5 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Clinics Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Clinics Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 12 Europe Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 13 Europe Monoclonal Antibodies Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe Monoclonal Antibodies Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Thymectomy Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Thymectomy Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Cholinesterase Inhibitors?Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Cholinesterase Inhibitors?Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Chronic Immunomodulators?Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Chronic Immunomodulators?Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Rapid Immunotherapies?Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Rapid Immunotherapies?Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Myasthenia Gravis Treatment Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Myasthenia Gravis Treatment Market by Country, 2023 - 2030, USD Million
TABLE 27 Germany Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 28 Germany Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 29 Germany Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 30 Germany Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 31 Germany Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 32 Germany Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 33 UK Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 34 UK Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 35 UK Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 36 UK Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 37 UK Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 38 UK Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 39 France Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 40 France Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 41 France Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 42 France Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 43 France Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 44 France Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 45 Russia Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 46 Russia Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 47 Russia Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 48 Russia Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 49 Russia Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 50 Russia Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 51 Spain Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 52 Spain Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 53 Spain Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 54 Spain Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 55 Spain Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 56 Spain Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 57 Italy Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 58 Italy Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 59 Italy Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 60 Italy Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 61 Italy Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 62 Italy Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 63 Rest of Europe Myasthenia Gravis Treatment Market, 2019 - 2022, USD Million
TABLE 64 Rest of Europe Myasthenia Gravis Treatment Market, 2023 - 2030, USD Million
TABLE 65 Rest of Europe Myasthenia Gravis Treatment Market by End-use, 2019 - 2022, USD Million
TABLE 66 Rest of Europe Myasthenia Gravis Treatment Market by End-use, 2023 - 2030, USD Million
TABLE 67 Rest of Europe Myasthenia Gravis Treatment Market by Type, 2019 - 2022, USD Million
TABLE 68 Rest of Europe Myasthenia Gravis Treatment Market by Type, 2023 - 2030, USD Million
TABLE 69 KEY INFORMATION – ASTRAZENECA PLC
TABLE 70 Key Information – Octapharma AG
TABLE 71 Key Information – Novartis AG
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 Key Information – Allergan PLC
TABLE 74 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 75 Key Information – GlaxoSmithKline PLC
TABLE 76 Key Information – Bausch Health Companies Inc
TABLE 77 key Information – Kedrion S.p.A
TABLE 78 Key Information – Zydus Lifesciences Ltd.